BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1559581)

  • 1. The significance of a residual mediastinal mass following treatment for aggressive non-Hodgkin's lymphomas.
    Tredaniel J; Brice P; Lepage E; Bris C; Marolleau JP; Ferme C; Hennequin C; Fermand JP; Frija J; Gisselbrecht C
    Eur Respir J; 1992 Feb; 5(2):170-3. PubMed ID: 1559581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gallium scan in the evaluation of post chemotherapy mediastinal residual masses of aggressive non-Hodgkin's lymphoma.
    Ulusakarya A; Lumbroso J; Casiraghi O; Koscielny S; Vantelon JM; Girinsky T; Tardivon A; Bourhis JH; Dartevelle P; Pico JL; Munck JN
    Leuk Lymphoma; 1999 Nov; 35(5-6):579-86. PubMed ID: 10609795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Residual abdominal masses in aggressive non-Hodgkin's lymphoma after combination chemotherapy: significance and management.
    Surbone A; Longo DL; DeVita VT; Ihde DC; Duffey PL; Jaffe ES; Solomon D; Hubbard SM; Young RC
    J Clin Oncol; 1988 Dec; 6(12):1832-7. PubMed ID: 3199167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.
    Dawson LA; Saito NG; Ratanatharathorn V; Uberti JP; Adams PT; Ayash LJ; Reynolds CM; Silver SM; Schipper MJ; Lichter AS; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):208-18. PubMed ID: 15093918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].
    Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M
    Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The significance of residual mediastinal abnormality on the chest radiograph following treatment for Hodgkin's disease.
    Radford JA; Cowan RA; Flanagan M; Dunn G; Crowther D; Johnson RJ; Eddleston B
    J Clin Oncol; 1988 Jun; 6(6):940-6. PubMed ID: 3373265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of residual mediastinal masses of thoracic lymphomas in children: impact on management and radiological follow-up strategy.
    Brisse H; Pacquement H; Burdairon E; Plancher C; Neuenschwander S
    Pediatr Radiol; 1998 Jun; 28(6):444-50. PubMed ID: 9634459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of adjuvant radiotherapy in the complex treatment of stage III-IV aggressive non-Hodgkin's lymphoma].
    Sotnikov VM; Pan'shin GA; Datsenko PV; Ivashin AV; Smol'tsova NN
    Vopr Onkol; 2009; 55(4):443-6. PubMed ID: 19947367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
    Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Primary gastrointestinal non-Hodgkin's lymphoma in two Hungarian regions].
    Kollár B; Rajnics P; Hunyady B; Zeleznik E; Jakucs J; Egyed M
    Orv Hetil; 2009 Aug; 150(35):1649-53. PubMed ID: 19692309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of primary mediastinal large B-cell lymphomas].
    Schneider T; Tóth E; Molnár Z; Várady E; Deák B; Horváth A; Horváth GI; Eid H; Schneider K; Lovey J; Keresztes S; Esik O; Lengyel Z; Rosta A
    Orv Hetil; 2004 Dec; 145(50):2531-7. PubMed ID: 15662753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The significance of the residual mediastinal mass in treated Hodgkin's disease.
    Jochelson M; Mauch P; Balikian J; Rosenthal D; Canellos G
    J Clin Oncol; 1985 May; 3(5):637-40. PubMed ID: 3998780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment results of tonsillar lymphoma: a 10-year experience.
    Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N
    Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of sonography in monitoring the therapeutic response of mediastinal lymphoma: comparison with chest radiography and CT.
    Wernecke K; Vassallo P; Hoffmann G; Peters PE; Poetter R; Rummeny E; Koch P
    AJR Am J Roentgenol; 1991 Feb; 156(2):265-72. PubMed ID: 1898797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of residual mediastinal-hilar Ga-67 uptake after treatment for Hodgkin's and non-Hodgkin's lymphomas: what degree of Ga-67 uptake is significant?
    Nikpoor N; Aliabadi P; Diaz L; Mannting F
    Clin Nucl Med; 2000 Dec; 25(12):959-62. PubMed ID: 11129161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
    Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma.
    Verdonck LF; van Putten WL; Hagenbeek A; Schouten HC; Sonneveld P; van Imhoff GW; Kluin-Nelemans HC; Raemaekers JM; van Oers RH; Haak HL
    N Engl J Med; 1995 Apr; 332(16):1045-51. PubMed ID: 7898521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors.
    Bessell EM; Graus F; Lopez-Guillermo A; Lewis SA; Villa S; Verger E; Petit J
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):501-8. PubMed ID: 15145169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous stem cell transplantation for aggressive non-Hodgkin's lymphomas in first complete or partial remission: a retrospective analysis of the outcome of 52 patients according to the age-adjusted International Prognostic Index.
    Fanin R; Silvestri F; Geromin A; Infanti L; Sperotto A; Cerno M; Stocchi R; Savignano C; Rinaldi C; Damiani D; Baccarani M
    Bone Marrow Transplant; 1998 Feb; 21(3):263-71. PubMed ID: 9489649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.